Cytisine induced urticaria : a case report during a smoking cessation treatment

Cytisine induced urticaria : a case report during a smoking cessation treatment

Authors

  • Simone Campagnari Department of Medicine, Addiction Medicine Unit, Verona University Hospital, 37134 Verona, Italy
  • Rebecca Casari Department of Medicine, Addiction Medicine Unit, Verona University Hospital, 37134 Verona, Italy
  • Lorenzo Zamboni a:1:{s:5:"en_US";s:146:"Unit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico “G.B. Rossi”, Verona, Italy";}
  • Francesca Fusina Padova Neuroscience Center, University of Padova, 35131 Padova, Italy
  • Fabio Lugoboni Department of Medicine, Addiction Medicine Unit, Verona University Hospital, 37134 Verona, Italy

Keywords:

Citisine, Tobacco, Addiction, Cigarette, Urticaria

Abstract

Cytisine is considered to be the oldest medication for smoking cessation and has been used for this purpose in some Eastern/Central European and Central Asian countries for over 50 years. Several sources points towards cytisine’s efficacy and effectiveness; it’s well tolerated when taken at the recommended dose, and adverse events reported in trials are typically non-serious and self-limiting gastrointestinal and sleep disturbances. We report a suspect case of urticaria during treatment for smoking cessation with cytisine in a woman of 48 years treated for smoking at the Unit of Addiction Medicine, Department of Internal Medicine, Hospital Trust of Verona, Italy.  The therapeutic protocol of cytisine that was used is of the "inductive" type; it consists in gradually increasing the daily capsules taken, with a parallel reduction in the number of cigarettes smoked until complete cessation between the fifth and ninth day of therapy (quit day) The number of capsules taken is then gradually reduced. She was treated for the firsts three days with betamethasone 1 mg/die, on the advice of her general practitioner, and suspended Cytisine. A week later the patient showed signs of recovery.

References

Prochaska JJ, Das S, Benowitz NL. Cytisine, the world{textquoteright}s oldest smoking cessation aid. BMJ. 2013;347. doi:10.1136/bmj.f5198

Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Addiction. 2019;114(11):1951-1969. doi:10.1111/add.14721

Coe JW, Brooks PR, Vetelino MG, et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48(10):3474-3477. doi:10.1021/jm050069n

Tutka P, Zatoński W. Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy. Pharmacol Rep. 2006;58(6):777-798.

Etter J-F. Cytisine for smoking cessation: a literature review and a meta-analysis. Arch Intern Med. 2006;166(15):1553-1559. doi:10.1001/archinte.166.15.1553

Walker N, Howe C, Glover M, et al. Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014;371(25):2353-2362. doi:10.1056/NEJMoa1407764

Walker N, Bullen C, Barnes J, et al. Getting cytisine licensed for use world-wide: a call to action. Addiction. 2016;111(11):1895-1898. doi:10.1111/add.13464

Downloads

Published

22-06-2022

Issue

Section

Case Reports: General Surgery and Miscellanea

How to Cite

1.
Campagnari S, Casari R, Zamboni L, Lugoboni F. Cytisine induced urticaria : a case report during a smoking cessation treatment. Acta Biomed [Internet]. 2022 Jun. 22 [cited 2024 Jul. 13];93(S1):e2022073. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/12450